Developmental Timing Determines the Protective Effect of Maternal Electroacupuncture on Perinatal Nicotine Exposure-Induced Offspring Lung Phenotype

被引:7
|
作者
Dai, Jian [1 ]
Ji, Bo [1 ]
Zhao, Guozhen [1 ]
Lu, Yawen [1 ]
Liu, Yitian [1 ]
Mou, Qiujie [1 ]
Sakurai, Reiko [2 ]
Xie, Yana [1 ]
Zhang, Qin [1 ]
Xu, Shuang [1 ]
Rehan, Virender K. [2 ]
机构
[1] Beijing Univ Chinese Med, Sch Acupuncture Moxibust & Tuina, Beijing 100029, Peoples R China
[2] Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Dept Pediat,Lundquist Inst Biomed Innovat, Los Angeles, CA 90095 USA
关键词
PITUITARY-ADRENAL AXIS; SECONDHAND SMOKE EXPOSURE; ALVEOLAR LIPOFIBROBLAST; PULMONARY-FUNCTION; PRENATAL NICOTINE; INDUCED ASTHMA; RAT MODEL; PREGNANCY; ACUPUNCTURE; BIRTH;
D O I
10.1155/2020/8030972
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction. Environmental exposure of the developing offspring to cigarette smoke or nicotine is an important predisposing factor for many chronic respiratory conditions, such as asthma, emphysema, pulmonary fibrosis, and so forth, in the exposed offspring. Studies showed that electroacupuncture (EA) applied to maternal "Zusanli" (ST36) acupoints during pregnancy and lactation protects against perinatal nicotine exposure- (PNE-) induced lung damage. However, the most effective time period, that is, prenatal vs. postnatal, to attain this effect has not been determined. Objective. To determine the most effective developmental timing of EA's protective effect against PNE-induced lung phenotype in the exposed offspring. Methods. Pregnant rats were given (1) saline ("S" group); (2) nicotine ("N" group); (3) nicotine + EA, exclusively prenatally ("Pre-EA" group); (4) nicotine + EA, exclusively postnatally ("Post-EA," group); and (5) nicotine + EA, administered both prenatally and postnatally ("Pre- and Post-EA" group). Nicotine was injected once daily (1 mg/kg, 100 mu l) and EA was administered to bilateral ST36 acupoints once daily during the specified time-periods. At the end of the experimental periods, key hypothalamic pituitary adrenal (HPA) axis markers in pups and dams, and lung function, morphometry, and the central molecular markers of lung development in the offspring were determined. Results. After nicotine exposure, alveolar mean linear intercept (MLI) increased, but mean alveolar number (MAN) decreased and lung PPAR gamma level decreased, but glucocorticoid receptor (GR) and serum corticosterone (Cort) levels increased, in line with the known PNE-induced lung phenotype. In the nicotine exposed group, maternal hypothalamic corticotropin releasing hormone (CRH) level decreased, but pituitary adrenocorticotropic hormone (ACTH) and serum Cort levels increased. In the "Pre- and Post-EA" groups, PNE-induced alterations in lung morphometry, lung development markers, and HPA axis were blocked. In the "Pre-EA" group, PNE-induced changes in lung morphometry, GR, and maternal HPA axis improved; lung PPAR gamma and serum Cort levels were slightly but not significantly improved. In contrast, the exclusive "Post-EA" group showed none of these benefits. Conclusions. Maternal EA applied to ST36 acupoints during both pre- and postnatal periods preserves offspring lung structure and function despite perinatal exposure to nicotine. EA applied during the "prenatal period" affords only limited benefits, whereas EA applied during the "postnatal period" is ineffective, suggesting that the EA's effects in modulating PNE-induced lung phenotype are limited to specific time-periods during lung development.
引用
收藏
页数:10
相关论文
共 31 条
  • [31] Lack of preventive effect of maternal exposure to α-glycosyl isoquercitrin and α-lipoic acid on developmental hypothyroidism-induced aberrations of hippocampal neurogenesis in rat offspring
    Masubuchi, Yasunori
    Tanaka, Takaharu
    Okada, Rena
    Ito, Yuko
    Nakahara, Junta
    Kikuchi, Satomi
    Watanabe, Yousuke
    Yoshida, Toshinori
    Maronpot, Robert R.
    Koyanagi, Mihoko
    Hayashi, Shim-mo
    Shibutani, Makoto
    JOURNAL OF TOXICOLOGIC PATHOLOGY, 2019, 32 (03) : 165 - 180